Alternatives to Guardant Health

Leveraging the adaptive immune system to diagnose and treat disease.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

AI-powered blood test for early cancer detection and subtyping.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Natera is a global leader in cell-free DNA testing, providing genetic testing services for reproductive health, oncology, and organ transplantation.

Personalized diagnostics for cancer genomic markers at the point of treatment.

Infiniplex offers a comprehensive cancer screening platform utilizing advanced AI and multi-omic analysis.

Empathy partners with financial institutions and employers to provide support solutions for life's hardest moments, easing logistical and emotional burdens.

Develops advanced diagnostic tools for healthcare using nanotechnology and AI.

Health sciences company focused on consumer health, longevity, and digital health solutions.

Leveraging nanotechnology and AI for early disease detection and improved healthcare.

AI-powered precision testing for patient identification in clinics and clinical trials.

A biotech spin-out from the University of Edinburgh developing novel bioprocessing solutions.

A global oncology company developing and commercializing innovative cancer treatments.